Evidence map›Paper›PMID 33096543›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2021

Klotho, PTSD, and advanced epigenetic age in cortical tissue.

Erika J Wolf, Ci-Di Chen, Xiang Zhao, Zhenwei Zhou, Filomene G Morrison, Nikolaos P Daskalakis, Annjanette Stone, Steven Schichman, Jaclyn Garza Grenier, Dana Fein-Schaffer and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Erika J WolfNational Center for PTSD at VA Boston Healthcare System, Boston, MA, USA. erika.wolf@va.gov.ORCID http://orcid.org/0000-0003-2666-2435
Ci-Di ChenDepartment of Biochemistry, Boston University School of Medicine, Boston, MA, USA.
Xiang ZhaoNational Center for PTSD at VA Boston Healthcare System, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1720-5996
Zhenwei ZhouNational Center for PTSD at VA Boston Healthcare System, Boston, MA, USA.
Filomene G MorrisonNational Center for PTSD at VA Boston Healthcare System, Boston, MA, USA.
Nikolaos P DaskalakisDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, MA, USA.ORCID http://orcid.org/0000-0003-1660-9112
Annjanette StonePharmacogenomics Analysis Laboratory, Research Service, Central Arkansas Veterans Healthcare System, Little Rock, AR, USA.
Steven SchichmanPharmacogenomics Analysis Laboratory, Research Service, Central Arkansas Veterans Healthcare System, Little Rock, AR, USA.
Jaclyn Garza GrenierBrigham and Women's Hospital, Channing Division of Network Medicine, Boston, MA, USA.
Dana Fein-SchafferNational Center for PTSD at VA Boston Healthcare System, Boston, MA, USA.
Bertrand R HuberPathology and Laboratory Medicine, VA Boston Healthcare System, Boston, MA, USA.
Traumatic Stress Brain Research Group
Carmela R AbrahamDepartment of Biochemistry, Boston University School of Medicine, Boston, MA, USA.
Mark W MillerNational Center for PTSD at VA Boston Healthcare System, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6393-8563
Mark W LogueNational Center for PTSD at VA Boston Healthcare System, Boston, MA, USA.
Boston University · USCentral Arkansas Veterans Healthcare System · USBrigham and Women's Hospital · USHarvard University · USVA Boston Healthcare System · US

Funding

Postdoctoral Training Program in Stress and TraumaT32MH019836 · NIMH · TUFTS UNIVERSITY BOSTON · PI DENISE M. SLOAN · 1996 to 2026
$4.7M
Neurobiological Correlates of Accelerated Cellular AgingR21AG061367 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLF, ERIKA J · 2019 to 2020
$347k
BLRD VA I01 BX003477NIA NIH HHS R21 AG061367NIMH NIH HHS T32 MH019836
6 · The paper itself

Abstract

This study examined the klotho (KL) longevity gene polymorphism rs9315202 and psychopathology, including posttraumatic stress disorder (PTSD), depression, and alcohol-use disorders, in association with advanced epigenetic age in three postmortem cortical tissue regions: dorsolateral and ventromedial prefrontal cortices and motor cortex. Using data from the VA National PTSD Brain Bank (n = 117), we found that rs9315202 interacted with PTSD to predict advanced epigenetic age in motor cortex among the subset of relatively older (>=45 years), white non-Hispanic decedents (corrected p = 0.014, n = 42). An evaluation of 211 additional common KL variants revealed that only variants in linkage disequilibrium with rs9315202 showed similarly high levels of significance. Alcohol abuse was nominally associated with advanced epigenetic age in motor cortex (p = 0.039, n = 114). The rs9315202 SNP interacted with PTSD to predict decreased KL expression via DNAm age residuals in motor cortex among older white non-Hispanics decedents (indirect β = -0.198, p = 0.027). Finally, in dual-luciferase enhancer reporter system experiments, we found that inserting the minor allele of rs9315202 in a human kidney cell line HK-2 genomic DNA resulted in a change in KL transcriptional activities, likely operating via long noncoding RNA in this region. This was the first study to examine multiple forms of psychopathology in association with advanced DNA methylation age across several brain regions, to extend work concerning the association between rs9315202 and advanced epigenetic to brain tissue, and to identify the effects of rs9315202 on KL gene expression. KL augmentation holds promise as a therapeutic intervention to slow the pace of cellular aging, disease onset, and neuropathology, particularly in older, stressed populations.

Indexed as

Stress Disorders, Post-TraumaticAgedAllelesDNA MethylationEpigenesis, GeneticEpigenomicsGlucuronidaseHumansKlotho ProteinsMiddle AgedGlucuronidaseKlotho Proteins

Identifiers

PMID33096543
PMCPMC8027437
OpenAlexW3094557333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.